Comparison between Sadhav Shipping IPO and Zenith Drugs IPO.
IPO Details
Sadhav Shipping IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Sadhav Shipping IPO is up to ₹36.25 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Sadhav Shipping IPO is ₹95.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
IPO Timetable
Sadhav Shipping IPO opens on Feb 23, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Sadhav Shipping IPO and Zenith Drugs IPO is Feb 27, 2024, and Feb 22, 2024, respectively.
| | Sadhav Shipping IPO | Zenith Drugs IPO |
|---|
| Anchor Bid Date | | Feb 16, 2024 |
| Issue Open | Feb 23, 2024 | Feb 19, 2024 |
| Issue Close | Feb 27, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 28, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 29, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 29, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Mar 01, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | | Mar 24, 2024 |
| Anchor Lockin End date 2 | | May 23, 2024 |
Financials & KPIs
Sadhav Shipping IPO P/E ratio is 12.66, as compared to Zenith Drugs IPO P/E ratio of 18.4.
Shares Offered
In the Sadhav Shipping IPO Retail Individual Investors (RII) are offered 19,08,000 shares while in Zenith Drugs IPO retail investors are offered 19,08,000 shares. Qualified Institutional Buyers (QIB) are offered in Sadhav Shipping IPO and 8,59,200 shares in Zenith Drugs IPO.
| | Sadhav Shipping IPO | Zenith Drugs IPO |
|---|
| Anchor Investor Reservation | | 12,88,000 shares |
| Market Maker Reservation | 2,02,800 shares | 8,52,800 shares |
| QIB | | 8,59,200 shares |
| NII | 19,08,000 shares | 6,44,800 shares |
| RII | 19,08,000 shares | 15,04,000 shares |
| Employee | | |
| Others | | |
| Total | 38,16,000 shares | 42,96,000 shares |
Bids Received (Subscription)
Sadhav Shipping IPO subscribed 135.69x in total, whereas Zenith Drugs IPO subscribed 179.18x.
